The stock market indices had a rough, volatile session and closed very weak. The day started out with some back and forth action, they pulled back midmorning, and was successful. They then rallied back to resistance, and then they plunged, acerbated by news that Emergent BioSolutions, Inc. (EBS) was having problems with withdrawals. Panic set in to take it to minus 15.44, and then they had a sharp rally acerbated to the upside when it was announced that QUALCOMM Incorporated (QCOM) may be acquiring NXP Semiconductors NV (NXPI). The semi-conductors took off and took the market with it. Biotech’s suffered all day, though, and in the afternoon the indices did pull back and closed near support.

Net on the day, the Dow was down 195.79 at 18,143.45. The S&P 500 was down 20.24 at 2151.13. The Nasdaq 100 was down 36.97 at 4838.30.

Advance-declines were 4 to 1 negative on the New York Stock Exchange, and 3 to 1 negative on the Nasdaq. Up/down volume was 3 to 1 negative on New York, total volume of 4.2 billion shares traded. The Nasdaq traded over 2 billion shares and had a 2 to 1 negative volume ratio.

TheTechTrader.com board was mostly red. Priceline.com (PCLN) was up 14.95 to 1472.98, and that was it. Amazon.com, Inc. (AMZN) closed nearly flat, up 33 to 829.05, but Alphabet Inc. (GOOG) was down 6.55 to 775.01, Apple Inc. (AAPL) down 1.78 to 112.17, and Netflix, Inc. (NFLX) down 81 cents to 96.67.

Baidu, Inc. (BIDU) dropped 5.51 to 182.23, and Facebook, Inc. (FB) gave back 1.14 to 128.09.

Tesla Motors, Inc. (TSLA) lost 5.57 to 200.70.

The only other point-plus gainers on our board today was Ambarella Inc. (AMBA), up 2.10 to 70.87.

On the downside, Supernus Pharmaceuticals, Inc. (SUPN) was down 2.05 to 24.63, Puma Biotechnology, Inc. (PBYI) down 1.20 to 66.06, Gigamon Inc. (GIMO) 1.04 to 55.09, Exelixis, Inc. (EXEL) 1.07 to 12.28, Fitbit Inc. (FIT) 1.88 to 14.82, and Clovis Oncology Inc (CLVS) 1.70 to 34.64.

The Direxion Daily S&P Biotech Bull 3X ETF (LABU) dropped 5.30 to 46.96.

Checking TheTechTrader.com percent-gain leaderboard, Aegerion Pharmaceuticals, Inc. (AEGR) bounced 57 cents, or 23%, to 3.06, on 6.3 million shares traded.

Catabasis Pharmaceuticals, Inc. (CATB) gained 1.77, or 40%, to 6.25, on 16.6 million shares traded.

Mimecast Limited (MIME) popped 1.81, or 11%, to 19.10, on 3.4 million shares traded.

The ProShares Ultra VIX Short-Term Futures (UVXY) jumped 1.97, or 12%, to 18.00, on 72.5 million shares traded. The Direxion Daily S&P Biotech Bear 3X ETF (LABD) advanced 1.66, or 10%, to 17.92, on 4.9 million shares traded. The VelocityShares 3x Long Crude Oil ETN (UWTI) climbed 1.40 to 23.61.

Stepping back and reviewing the hourly chart patterns, the indices were down sharply by midday, rallied in the afternoon, but pulled back in the last half hour to close negative on the day. It was a nasty pullback day, but we’ve had four days in a row of up, down, back up, and back down.

Let’s see what happens tomorrow.

Good Trading!

Harry

For more of Harry Boxer, sign up for a FREE 15-Day Trial to his Real-Time Technical Trading Diary. Or sign up for a Free 30-Day Trial to his Top Charts of the Week service.

(c) 2016 AdviceTrade, Inc. All rights reserved. Distributed only by written permission of AdviceTrade and The Technical Trader at info@advicetrade.com . In using any portion of Harry Boxer's content, you agree to the terms and conditions governing the use of the service as described in our disclaimer at http://www.thetechtrader.com

Mr. Boxer's commentaries and index analysis represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Trades mentioned on the site are hypothetical, not actual, positions.

Harry Boxer Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.